Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.14 trillion and total revenue of $111.37 billion.
Market Cap
1.14T
Revenue
111.37B
Profits
-41.09B
PE Ratio
n/a
Profit Margin
-36.90%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.45B | 1.24% | 1,264,168 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 72.52B | -0.30% | 982,313 | 14.92B |
| 3 | ARGX | argenx SE | 50.65B | 3.98% | 497,992 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.03B | -3.46% | 1,287,747 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 34.55B | -0.44% | 346,708 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.65B | 1.65% | 1,640,884 | - |
| 7 | RPRX | Royalty Pharma plc | 29.74B | 1.69% | 2,732,726 | 2.44B |
| 8 | BNTX | BioNTech SE | 23.60B | -0.84% | 647,660 | 3.23B |
| 9 | INSM | Insmed Incorporated | 22.52B | 2.51% | 7,898,445 | 819.56M |
| 10 | MRNA | Moderna, Inc. | 20.98B | -2.70% | 25,400,747 | 2.23B |
| 11 | ROIV | Roivant Sciences Ltd. | 20.73B | 1.40% | 4,199,128 | 13.31M |
| 12 | INCY | Incyte Corporation | 20.04B | 1.79% | 1,662,287 | 5.36B |
| 13 | GMAB | Genmab A/S | 16.06B | -0.95% | 2,646,771 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 14.82B | - | 682,348 | 998.25M |
| 15 | SMMT | Summit Therapeutics Inc. | 14.48B | 3.21% | 4,233,547 | - |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 14.03B | -0.97% | 963,832 | 4.44B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 12.67B | -4.02% | 3,464,985 | 579.96M |
| 18 | EXEL | Exelixis, Inc. | 12.49B | 3.22% | 3,619,006 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.46B | -0.44% | 1,533,662 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.46B | -2.55% | 307,706 | 1.13B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.14B | -0.42% | 738,134 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.95B | 6.95% | 2,290,046 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.16B | -2.74% | 2,291,611 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.71B | -0.50% | 678,110 | 5.37M |
| 25 | CYTK | Cytokinetics, Incorporated | 9.28B | -3.06% | 5,316,877 | 105.82M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.25B | 0.54% | 749,026 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.22B | 2.35% | 386,489 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.49B | -4.70% | 14,502,080 | 140.98M |
| 29 | NUVL | Nuvalent, Inc. | 8.26B | -0.76% | 334,571 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.87B | 3.57% | 2,923,099 | 1.51B |
| 31 | PCVX | Vaxcyte, Inc. | 7.80B | 1.85% | 1,514,859 | - |
| 32 | TECH | Bio-Techne Corporation | 7.42B | -1.94% | 2,695,066 | 1.21B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.92B | -2.30% | 486,213 | 51.48M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 6.66B | 4.17% | 572,030 | 74.06M |
| 35 | SYRE | Spyre Therapeutics, Inc. | 6.64B | 1.84% | 1,333,179 | - |
| 36 | MIRM | Mirum Pharmaceuticals, Inc. | 6.47B | -0.92% | 528,494 | 569.61M |
| 37 | PTCT | PTC Therapeutics, Inc. | 6.37B | 4.29% | 3,208,841 | 827.11M |
| 38 | APGE | Apogee Therapeutics, Inc. | 6.34B | 1.89% | 896,786 | - |
| 39 | CNTA | Centessa Pharmaceuticals plc | 6.13B | - | 974,664 | 15.00M |
| 40 | CGON | CG Oncology, Inc. | 6.11B | -0.43% | 649,809 | 5.07M |
| 41 | TGTX | TG Therapeutics, Inc. | 6.11B | 0.65% | 2,782,179 | 700.35M |
| 42 | CELC | Celcuity Inc. | 6.07B | -4.14% | 946,526 | - |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.99B | -7.20% | 1,068,582 | 217.17M |
| 44 | BLTE | Belite Bio, Inc | 5.98B | -1.88% | 67,284 | - |
| 45 | IMVT | Immunovant, Inc. | 5.91B | 0.41% | 1,150,722 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 5.83B | -1.84% | 1,070,865 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.79B | -0.08% | 1,005,155 | - |
| 48 | CORT | Corcept Therapeutics Incorporated | 5.50B | -2.07% | 1,081,937 | 769.10M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.39B | -1.17% | 714,841 | 7.50M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | -0.02% | 7,588,361 | 1.11B |
| 51 | CRSP | CRISPR Therapeutics AG | 5.21B | -1.50% | 1,317,499 | 4.10M |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 4.76B | 0.47% | 254,979 | 1.34M |
| 53 | LEGN | Legend Biotech Corporation | 4.73B | -9.03% | 3,048,689 | 1.03B |
| 54 | NAMS | NewAmsterdam Pharma Company N.V. | 4.55B | 2.22% | 3,163,002 | 22.57M |
| 55 | CAI | Caris Life Sciences, Inc. | 4.51B | -1.30% | 3,256,054 | 907.29M |
| 56 | MANE | Veradermics, Incorporated | 4.45B | 1.87% | 386,699 | - |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.42B | -0.42% | 197,765 | 274.48M |
| 58 | TVTX | Travere Therapeutics, Inc. | 4.05B | 2.14% | 2,455,897 | 536.20M |
| 59 | ORKA | Oruka Therapeutics, Inc. | 3.93B | 1.69% | 937,692 | - |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.85B | -2.48% | 1,927,093 | 18.07M |
| 61 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.80B | - | 3,682,457 | 596.96M |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.73B | -2.68% | 1,944,008 | 1.10B |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.72B | -2.15% | 1,096,570 | - |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.68B | 1.24% | 1,960,646 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.68B | 1.40% | 162,365 | 803.79M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.39B | 2.00% | 1,143,801 | 62.38M |
| 67 | ERAS | Erasca, Inc. | 3.25B | 3.16% | 3,804,401 | - |
| 68 | BEAM | Beam Therapeutics Inc. | 3.16B | -1.76% | 2,410,397 | 164.01M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.13B | -1.97% | 637,930 | 236.00M |
| 70 | DNLI | Denali Therapeutics Inc. | 3.12B | 0.25% | 1,834,085 | - |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.05B | 4.83% | 1,182,011 | - |
| 72 | ALMS | Alumis Inc. | 3.01B | - | 962,692 | 24.05M |
| 73 | KLRA | Kailera Therapeutics, Inc. | 2.97B | 6.80% | 482,851 | - |
| 74 | SLNO | Soleno Therapeutics, Inc. | 2.76B | -0.02% | 1,484,436 | 285.01M |
| 75 | GPCR | Structure Therapeutics Inc. | 2.72B | -1.99% | 694,711 | - |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 2.66B | 0.33% | 3,327,273 | 415.62M |
| 77 | NKTR | Nektar Therapeutics | 2.66B | -3.87% | 1,748,052 | 55.63M |
| 78 | IRON | Disc Medicine, Inc. | 2.64B | 1.42% | 518,542 | - |
| 79 | VERA | Vera Therapeutics, Inc. | 2.63B | 1.16% | 1,147,378 | - |
| 80 | IMNM | Immunome, Inc. | 2.60B | 2.50% | 1,277,645 | 6.94M |
| 81 | RARE | Ultragenyx Pharmaceutical Inc. | 2.58B | 0.69% | 1,712,477 | 670.00M |
| 82 | TARS | Tarsus Pharmaceuticals, Inc. | 2.57B | -2.55% | 1,007,870 | 535.08M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.53B | -4.97% | 960,325 | 865.00K |
| 84 | KOD | Kodiak Sciences Inc. | 2.49B | -2.83% | 1,261,869 | - |
| 85 | IDYA | IDEAYA Biosciences, Inc. | 2.47B | -0.67% | 980,354 | 225.27M |
| 86 | RLAY | Relay Therapeutics, Inc. | 2.46B | 0.71% | 2,076,140 | 10.68M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.45B | 0.64% | 718,913 | - |
| 88 | NBTX | Nanobiotix S.A. | 2.41B | 17.72% | 203,707 | 38.27M |
| 89 | ELVN | Enliven Therapeutics, Inc. | 2.41B | -2.85% | 705,275 | - |
| 90 | DFTX | Definium Therapeutics, Inc. | 2.33B | -2.95% | 1,482,675 | - |
| 91 | ZLAB | Zai Lab Limited | 2.20B | 5.32% | 984,208 | 453.28M |
| 92 | TRVI | Trevi Therapeutics, Inc. | 2.11B | 2.62% | 1,131,733 | - |
| 93 | SION | Sionna Therapeutics, Inc. | 2.07B | 3.89% | 670,726 | - |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 2.05B | -2.81% | 3,072,520 | 2.18B |
| 95 | STOK | Stoke Therapeutics, Inc. | 2.03B | -0.76% | 461,073 | 32.08M |
| 96 | OCUL | Ocular Therapeutix, Inc. | 2.03B | -3.83% | 3,520,980 | 52.04M |
| 97 | TYRA | Tyra Biosciences, Inc. | 2.02B | -0.90% | 407,906 | - |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | 3.22% | 2,182,663 | 298.30M |
| 99 | NTLA | Intellia Therapeutics, Inc. | 2.01B | 2.34% | 7,237,844 | 66.09M |
| 100 | AAPG | Ascentage Pharma Group International | 2.00B | 0.74% | 1,455 | 82.08M |
| 101 | TSHA | Taysha Gene Therapies, Inc. | 1.96B | 0.15% | 1,770,139 | 7.47M |
| 102 | PHVS | Pharvaris N.V. | 1.96B | -0.47% | 844,023 | - |
| 103 | ANAB | AnaptysBio, Inc. | 1.95B | -2.03% | 504,136 | 234.60M |
| 104 | OCS | Oculis Holding AG | 1.93B | 0.03% | 629,009 | 1.51M |
| 105 | MBX | MBX Biosciences, Inc. | 1.91B | -2.17% | 1,886,135 | - |
| 106 | SNDX | Syndax Pharmaceuticals, Inc. | 1.89B | -0.51% | 2,157,197 | 217.17M |
| 107 | MESO | Mesoblast Limited | 1.88B | -1.56% | 139,254 | 65.38M |
| 108 | INBX | Inhibrx Biosciences, Inc. | 1.86B | -5.04% | 1,329,824 | 1.30M |
| 109 | CAPR | Capricor Therapeutics, Inc. | 1.85B | 5.00% | 1,671,012 | 11.13M |
| 110 | RAPP | Rapport Therapeutics, Inc. | 1.84B | 1.03% | 548,100 | 20.00M |
| 111 | GENB | Generate Biomedicines, Inc. | 1.83B | 5.20% | 358,818 | 30.30M |
| 112 | ADMA | ADMA Biologics, Inc. | 1.83B | -3.55% | 8,592,927 | 509.86M |
| 113 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -3.99% | 194,448 | 1.20B |
| 114 | VRDN | Viridian Therapeutics, Inc. | 1.77B | 3.55% | 3,205,273 | 70.92M |
| 115 | ZYME | Zymeworks Inc. | 1.75B | 0.59% | 1,185,231 | 81.26M |
| 116 | PVLA | Palvella Therapeutics, Inc. | 1.75B | 0.66% | 338,979 | - |
| 117 | HRMY | Harmony Biosciences Holdings, Inc. | 1.75B | -2.61% | 796,422 | 899.11M |
| 118 | QURE | uniQure N.V. | 1.74B | -0.07% | 2,694,754 | 18.09M |
| 119 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | -1.81% | 14,017,303 | 66.41M |
| 120 | GLUE | Monte Rosa Therapeutics, Inc. | 1.71B | 4.49% | 1,042,695 | 42.95M |
| 121 | NRIX | Nurix Therapeutics, Inc. | 1.68B | -1.45% | 660,433 | 71.78M |
| 122 | VCEL | Vericel Corporation | 1.68B | -1.61% | 759,846 | 292.09M |
| 123 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | 0.72% | 794,276 | 66.05M |
| 124 | INVA | Innoviva, Inc. | 1.66B | -1.62% | 800,994 | 420.69M |
| 125 | NUVB | Nuvation Bio Inc. | 1.66B | -0.63% | 2,779,618 | 143.05M |
| 126 | IOVA | Iovance Biotherapeutics, Inc. | 1.65B | 2.21% | 19,047,401 | 285.61M |
| 127 | ARDX | Ardelyx, Inc. | 1.63B | -2.51% | 4,044,595 | 427.68M |
| 128 | ABCL | AbCellera Biologics Inc. | 1.60B | 0.19% | 13,448,736 | 75.13M |
| 129 | VIR | Vir Biotechnology, Inc. | 1.57B | 1.86% | 1,833,441 | 65.50M |
| 130 | NVAX | Novavax, Inc. | 1.56B | -6.03% | 10,343,095 | 596.34M |
| 131 | IMTX | Immatics N.V. | 1.55B | 1.50% | 519,102 | 56.67M |
| 132 | URGN | UroGen Pharma Ltd. | 1.53B | 6.56% | 1,288,653 | 140.49M |
| 133 | BCAX | Bicara Therapeutics Inc. | 1.50B | 1.51% | 656,906 | - |
| 134 | PGEN | Precigen, Inc. | 1.49B | -0.24% | 1,945,067 | 9.68M |
| 135 | ATAI | AtaiBeckley Inc. | 1.48B | 0.25% | 3,388,065 | 4.09M |
| 136 | DMRA | Damora Therapeutics, Inc. | 1.47B | 0.79% | 250,719 | - |
| 137 | IMCR | Immunocore Holdings plc | 1.47B | -2.47% | 157,661 | 412.81M |
| 138 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | -0.07% | 1,935,733 | 73.62M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.42B | -2.85% | 1,196,660 | 2.71B |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.41B | -1.96% | 545,810 | 2.50M |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.37B | 10.43% | 3,342,739 | - |
| 142 | BHVN | Biohaven Ltd. | 1.37B | -7.91% | 1,945,852 | - |
| 143 | MPLT | MapLight Therapeutics, Inc. | 1.36B | 9.82% | 288,240 | - |
| 144 | WVE | Wave Life Sciences Ltd. | 1.36B | -1.53% | 3,009,346 | 71.80M |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.35B | -1.63% | 271,233 | - |
| 146 | CRVS | Corvus Pharmaceuticals, Inc. | 1.33B | 1.67% | 1,141,096 | - |
| 147 | GHRS | GH Research PLC | 1.32B | -0.75% | 110,469 | - |
| 148 | SVRA | Savara Inc. | 1.30B | -2.10% | 1,051,596 | - |
| 149 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | -0.27% | 1,306,396 | - |
| 150 | AVLN | Avalyn Pharma Inc. | 1.24B | 8.20% | 306,734 | - |
| 151 | IVA | Inventiva S.A. | 1.23B | 8.01% | 1,101,060 | 7.94M |
| 152 | JBIO | Jade Biosciences, Inc. | 1.23B | -3.68% | 449,737 | - |
| 153 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.22B | -2.27% | 4,736,550 | 204.73M |
| 154 | DBVT | DBV Technologies S.A. | 1.22B | 3.00% | 173,821 | 5.74M |
| 155 | ZBIO | Zenas BioPharma, Inc. | 1.21B | 3.87% | 384,487 | 10.00M |
| 156 | EYPT | EyePoint, Inc. | 1.17B | 2.34% | 989,485 | 7.61M |
| 157 | COAG | Hemab Therapeutics Holdings, Inc. | 1.10B | -0.48% | 239,335 | - |
| 158 | SEPN | Septerna, Inc. | 1.06B | -1.26% | 132,725 | 72.26M |
| 159 | MNKD | MannKind Corporation | 1.04B | -4.55% | 7,537,864 | 360.78M |
| 160 | OMER | Omeros Corporation | 1.04B | 1.63% | 800,115 | - |
| 161 | AKTS | Aktis Oncology, Inc. | 1.01B | -1.77% | 134,298 | 8.28M |
| 162 | SANA | Sana Biotechnology, Inc. | 987.90M | 1.42% | 2,270,434 | - |
| 163 | LXRX | Lexicon Pharmaceuticals, Inc. | 978.70M | 15.50% | 13,977,932 | 69.64M |
| 164 | DSGN | Design Therapeutics, Inc. | 974.95M | 9.77% | 742,466 | - |
| 165 | PHAT | Phathom Pharmaceuticals, Inc. | 970.64M | 0.49% | 919,129 | 204.89M |
| 166 | SLS | SELLAS Life Sciences Group, Inc. | 968.80M | 4.79% | 6,382,624 | - |
| 167 | XNCR | Xencor, Inc. | 948.27M | -0.54% | 643,733 | 97.36M |
| 168 | LBRX | LB Pharmaceuticals Inc | 937.55M | 2.27% | 78,781 | - |
| 169 | VOR | Vor Biopharma Inc. | 934.70M | 1.83% | 1,387,852 | - |
| 170 | ANNX | Annexon, Inc. | 930.63M | -0.18% | 2,275,063 | - |
| 171 | ORIC | ORIC Pharmaceuticals, Inc. | 930.62M | 1.58% | 1,163,584 | - |
| 172 | PHAR | Pharming Group N.V. | 920.47M | -2.75% | 24,070 | 369.49M |
| 173 | MGTX | MeiraGTx Holdings plc | 916.48M | 0.81% | 687,179 | 81.39M |
| 174 | DRTS | Alpha Tau Medical Ltd. | 910.02M | 21.50% | 4,924,758 | - |
| 175 | CGEM | Cullinan Therapeutics, Inc. | 905.28M | 1.24% | 875,868 | - |
| 176 | ABSI | Absci Corporation | 901.13M | -2.03% | 6,371,132 | 1.84M |
| 177 | GERN | Geron Corporation | 891.71M | - | 32,391,548 | 196.12M |
| 178 | JANX | Janux Therapeutics, Inc. | 867.81M | 0.35% | 751,764 | 13.73M |
| 179 | ABUS | Arbutus Biopharma Corporation | 864.57M | 1.15% | 766,298 | 14.08M |
| 180 | ANRO | Alto Neuroscience, Inc. | 859.84M | 1.11% | 389,448 | - |
| 181 | SPRY | ARS Pharmaceuticals, Inc. | 853.99M | -1.60% | 1,296,357 | 84.28M |
| 182 | TBPH | Theravance Biopharma, Inc. | 851.66M | -2.88% | 410,517 | 109.78M |
| 183 | AURA | Aura Biosciences, Inc. | 850.05M | -2.50% | 333,965 | - |
| 184 | KURA | Kura Oncology, Inc. | 844.13M | 0.96% | 1,181,744 | 67.48M |
| 185 | CTMX | CytomX Therapeutics, Inc. | 840.30M | -3.02% | 3,647,185 | 35.54M |
| 186 | DRUG | Bright Minds Biosciences Inc. | 836.91M | 1.23% | 149,003 | - |
| 187 | EVMN | Evommune, Inc. | 835.99M | 1.27% | 668,318 | 10.00M |
| 188 | ODTX | Odyssey Therapeutics, Inc. | 823.19M | 6.27% | 426,806 | 2.98M |
| 189 | SPTX | Seaport Therapeutics, Inc. | 808.67M | -4.98% | 399,583 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 794.21M | 1.50% | 25,541 | - |
| 191 | ALLO | Allogene Therapeutics, Inc. | 784.27M | - | 4,503,825 | 22.00K |
| 192 | RLMD | Relmada Therapeutics, Inc. | 771.98M | 0.55% | 894,452 | - |
| 193 | SLDB | Solid Biosciences Inc. | 755.81M | 5.64% | 972,360 | - |
| 194 | TENX | Tenax Therapeutics, Inc. | 703.60M | 2.49% | 1,382,557 | - |
| 195 | ACRS | Aclaris Therapeutics, Inc. | 691.34M | 0.41% | 1,814,840 | 8.37M |
| 196 | FBRX | Forte Biosciences, Inc. | 659.40M | 8.24% | 435,928 | - |
| 197 | TRAX | First Tracks Biotherapeutics, Inc. | 651.89M | -3.99% | 345,549 | - |
| 198 | STRO | Sutro Biopharma, Inc. | 651.28M | -2.31% | 198,258 | 102.48M |
| 199 | CADL | Candel Therapeutics, Inc. | 648.44M | 5.99% | 3,891,795 | - |
| 200 | GYRE | Gyre Therapeutics, Inc. | 647.83M | -5.09% | 59,879 | 117.05M |
| 201 | ZVRA | Zevra Therapeutics, Inc. | 638.44M | -2.96% | 2,235,092 | 122.29M |
| 202 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 631.46M | 3.00% | 468,094 | - |
| 203 | KYTX | Kyverna Therapeutics, Inc. | 625.88M | 10.59% | 1,295,761 | - |
| 204 | ARVN | Arvinas, Inc. | 623.24M | -4.45% | 1,421,448 | 89.40M |
| 205 | CABA | Cabaletta Bio, Inc. | 622.85M | -1.55% | 5,306,173 | - |
| 206 | CBIO | Crescent Biopharma, Inc. | 615.40M | -1.28% | 549,551 | 11.88M |
| 207 | VALN | Valneva SE | 611.89M | 12.70% | 116,635 | 205.07M |
| 208 | CRMD | CorMedix Inc. | 600.87M | -3.28% | 1,112,419 | 311.71M |
| 209 | ALT | Altimmune, Inc. | 600.08M | - | 2,937,164 | 41.00K |
| 210 | AGMB | AgomAb Therapeutics NV | 599.84M | 0.41% | 119,419 | - |
| 211 | PRME | Prime Medicine, Inc. | 585.20M | 0.93% | 3,193,933 | 4.03M |
| 212 | DNA | Ginkgo Bioworks Holdings, Inc. | 566.36M | -2.91% | 1,620,624 | 151.40M |
| 213 | FDMT | 4D Molecular Therapeutics, Inc. | 564.06M | 6.41% | 1,021,745 | 88.24M |
| 214 | AVTX | Avalo Therapeutics, Inc. | 540.97M | -6.12% | 2,881,479 | 59.00K |
| 215 | EIKN | Eikon Therapeutics, Inc. | 538.68M | -0.10% | 634,769 | - |
| 216 | PROK | ProKidney Corp. | 534.47M | -4.84% | 1,329,454 | 893.00K |
| 217 | CLYM | Climb Bio, Inc. | 531.19M | -2.20% | 1,248,701 | - |
| 218 | STTK | Shattuck Labs, Inc. | 530.58M | 2.48% | 452,707 | 1.00M |
| 219 | MDXG | MiMedx Group, Inc. | 530.25M | -1.11% | 2,452,411 | 389.42M |
| 220 | IMMX | Immix Biopharma, Inc. | 525.88M | 1.74% | 658,577 | - |
| 221 | RGNX | REGENXBIO Inc. | 520.30M | -4.45% | 1,581,318 | 170.44M |
| 222 | TECX | Tectonic Therapeutic, Inc. | 519.28M | -5.10% | 548,529 | - |
| 223 | ANL | Adlai Nortye Ltd. | 518.40M | -2.41% | 167,468 | 5.00M |
| 224 | CTNM | Contineum Therapeutics, Inc. | 509.64M | -6.06% | 149,536 | - |
| 225 | PRTA | Prothena Corporation plc | 506.26M | -9.88% | 845,931 | 57.94M |
| 226 | OCGN | Ocugen, Inc. | 501.00M | -1.99% | 9,629,028 | 4.47M |
| 227 | UPB | Upstream Bio, Inc. | 495.77M | 0.22% | 377,652 | 2.85M |
| 228 | XOMA | XOMA Royalty Corporation | 495.10M | -0.81% | 119,367 | 52.15M |
| 229 | RIGL | Rigel Pharmaceuticals, Inc. | 484.75M | 0.61% | 377,006 | 299.77M |
| 230 | ASMB | Assembly Biosciences, Inc. | 483.29M | 2.25% | 87,309 | 71.10M |
| 231 | PRLD | Prelude Therapeutics Incorporated | 482.77M | -1.23% | 343,725 | 12.14M |
| 232 | OVID | Ovid Therapeutics Inc. | 482.77M | -0.36% | 3,794,438 | 7.25M |
| 233 | NGNE | Neurogene Inc. | 481.67M | 0.21% | 116,643 | 925.00K |
| 234 | LXEO | Lexeo Therapeutics, Inc. | 480.55M | 4.97% | 964,976 | - |
| 235 | SGMT | Sagimet Biosciences Inc. | 474.87M | -0.26% | 896,933 | - |
| 236 | FULC | Fulcrum Therapeutics, Inc. | 466.43M | -0.14% | 633,928 | 80.00M |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 455.40M | -0.40% | 53,496 | - |
| 238 | ZURA | Zura Bio Limited | 450.68M | -0.84% | 1,125,307 | - |
| 239 | ENTA | Enanta Pharmaceuticals, Inc. | 448.64M | 0.78% | 298,486 | 69.21M |
| 240 | LYEL | Lyell Immunopharma, Inc. | 447.98M | -0.67% | 97,140 | 31.00K |
| 241 | ADCT | ADC Therapeutics SA | 442.63M | -0.57% | 1,100,240 | 79.18M |
| 242 | MNPR | Monopar Therapeutics Inc. | 438.47M | 3.05% | 166,547 | - |
| 243 | PRTC | PureTech Health plc | 437.17M | 1.81% | 33,105 | 4.66M |
| 244 | AVIR | Atea Pharmaceuticals, Inc. | 432.95M | -0.37% | 230,759 | - |
| 245 | VSTM | Verastem, Inc. | 428.82M | -0.20% | 3,083,312 | 49.59M |
| 246 | IVVD | Invivyd, Inc. | 427.03M | 0.67% | 2,834,876 | 53.43M |
| 247 | LRMR | Larimar Therapeutics, Inc. | 424.88M | 3.02% | 1,826,515 | - |
| 248 | AUTL | Autolus Therapeutics plc | 420.51M | 0.64% | 1,285,212 | 75.39M |
| 249 | BNTC | Benitec Biopharma Inc. | 413.80M | -1.63% | 74,605 | - |
| 250 | IPSC | Century Therapeutics, Inc. | 413.01M | - | 808,001 | 109.16M |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 409.14M | 1.58% | 449,868 | 9.01M |
| 252 | RCKT | Rocket Pharmaceuticals, Inc. | 392.00M | -1.10% | 2,229,361 | - |
| 253 | NAUT | Nautilus Biotechnology, Inc. | 383.78M | 12.69% | 1,181,253 | - |
| 254 | VTVT | vTv Therapeutics Inc. | 377.99M | -0.72% | 21,338 | 17.00K |
| 255 | VNDA | Vanda Pharmaceuticals Inc. | 377.05M | -0.16% | 1,297,538 | 217.78M |
| 256 | YDES | YD Bio Limited | 373.40M | - | 3,426 | 510.36K |
| 257 | IRD | Opus Genetics, Inc. | 365.58M | 2.61% | 845,315 | 14.20M |
| 258 | PBYI | Puma Biotechnology, Inc. | 363.42M | -4.67% | 394,748 | 227.18M |
| 259 | CCCC | C4 Therapeutics, Inc. | 349.27M | 7.46% | 2,989,153 | 35.95M |
| 260 | DMAC | DiaMedica Therapeutics Inc. | 347.55M | 2.06% | 117,731 | - |
| 261 | IKT | Inhibikase Therapeutics, Inc. | 346.02M | -1.46% | 506,841 | 1.00 |
| 262 | NMRA | Neumora Therapeutics, Inc. | 341.63M | 2.19% | 1,465,247 | - |
| 263 | SLN | Silence Therapeutics plc | 338.67M | 2.87% | 112,476 | 839.00K |
| 264 | IMRX | Immuneering Corporation | 336.43M | -0.38% | 557,973 | - |
| 265 | SRZN | Surrozen, Inc. | 336.33M | 1.10% | 95,485 | 7.49M |
| 266 | GLSI | Greenwich LifeSciences, Inc. | 334.31M | 5.56% | 264,566 | - |
| 267 | ABEO | Abeona Therapeutics Inc. | 333.33M | -0.68% | 1,006,644 | 5.82M |
| 268 | CMPX | Compass Therapeutics, Inc. | 329.56M | - | 5,811,889 | 850.00K |
| 269 | RZLT | Rezolute, Inc. | 329.27M | -1.25% | 1,322,711 | - |
| 270 | BCYC | Bicycle Therapeutics plc | 327.62M | -2.29% | 202,536 | 63.50M |
| 271 | LCTX | Lineage Cell Therapeutics, Inc. | 326.58M | -4.38% | 1,650,678 | 14.56M |
| 272 | PALI | Palisade Bio, Inc. | 324.80M | 7.78% | 2,828,342 | - |
| 273 | ARMP | Armata Pharmaceuticals, Inc. | 323.65M | 6.27% | 59,763 | 4.90M |
| 274 | NAGE | Niagen Bioscience, Inc. | 317.65M | -4.56% | 1,951,776 | 130.42M |
| 275 | LENZ | LENZ Therapeutics, Inc. | 313.23M | -0.70% | 741,270 | 20.99M |
| 276 | NGEN | NervGen Pharma Corp. | 309.97M | 2.13% | 297,962 | - |
| 277 | REPL | Replimune Group, Inc. | 308.82M | -8.11% | 7,633,642 | - |
| 278 | CHRS | Coherus Oncology, Inc. | 300.72M | 11.43% | 3,713,116 | 46.88M |
| 279 | AVXL | Anavex Life Sciences Corp. | 300.26M | 0.62% | 1,063,156 | - |
| 280 | EDIT | Editas Medicine, Inc. | 299.59M | -1.61% | 1,095,538 | 38.69M |
| 281 | ACHV | Achieve Life Sciences, Inc. | 297.61M | 7.29% | 2,183,367 | - |
| 282 | ZNTL | Zentalis Pharmaceuticals, Inc. | 293.65M | -6.12% | 723,361 | 26.87M |
| 283 | NVCT | Nuvectis Pharma, Inc. | 293.37M | -5.06% | 92,013 | - |
| 284 | ELDN | Eledon Pharmaceuticals, Inc. | 290.19M | -1.55% | 896,913 | - |
| 285 | TARA | Protara Therapeutics, Inc. | 290.17M | - | 767,190 | - |
| 286 | CLLS | Cellectis S.A. | 288.96M | 3.38% | 29,007 | 79.59M |
| 287 | ACIU | AC Immune SA | 280.74M | -1.05% | 310,158 | 4.62M |
| 288 | ALXO | ALX Oncology Holdings Inc. | 279.88M | - | 891,611 | - |
| 289 | CGEN | Compugen Ltd. | 271.37M | -1.03% | 444,138 | 72.76M |
| 290 | ARTV | Artiva Biotherapeutics, Inc. | 262.00M | -2.66% | 864,833 | 251.00K |
| 291 | SABS | SAB Biotherapeutics, Inc. | 261.43M | -9.49% | 2,627,158 | 114.70K |
| 292 | HELP | Cybin Inc. | 255.18M | -3.95% | 777,820 | - |
| 293 | FHTX | Foghorn Therapeutics Inc. | 254.23M | -2.48% | 123,025 | 28.22M |
| 294 | FATE | Fate Therapeutics, Inc. | 253.49M | -8.79% | 3,424,145 | 6.65M |
| 295 | TRDA | Entrada Therapeutics, Inc. | 252.23M | 2.34% | 794,468 | 5.74M |
| 296 | RNAC | Cartesian Therapeutics, Inc. | 250.62M | -1.39% | 279,631 | 1.78M |
| 297 | ADAG | Adagene Inc. | 250.42M | 2.71% | 80,592 | 7.67M |
| 298 | VYGR | Voyager Therapeutics, Inc. | 248.94M | 1.73% | 449,597 | 36.49M |
| 299 | NERV | Minerva Neurosciences, Inc. | 246.83M | -4.25% | 66,537 | - |
| 300 | FENC | Fennec Pharmaceuticals Inc. | 246.46M | 2.45% | 142,322 | 44.64M |
| 301 | ARCT | Arcturus Therapeutics Holdings Inc. | 245.43M | -6.34% | 498,848 | 54.71M |
| 302 | NBP | NovaBridge Biosciences | 242.86M | -4.55% | 792,716 | - |
| 303 | OABI | OmniAb, Inc. | 242.10M | 0.60% | 702,081 | 28.94M |
| 304 | CDXS | Codexis, Inc. | 240.88M | -7.02% | 1,413,801 | 78.09M |
| 305 | KROS | Keros Therapeutics, Inc. | 237.65M | -0.50% | 262,509 | 244.06M |
| 306 | OBIO | Orchestra BioMed Holdings, Inc. | 234.13M | -3.22% | 193,319 | 33.48M |
| 307 | MIST | Milestone Pharmaceuticals Inc. | 233.03M | -1.04% | 964,557 | 1.55M |
| 308 | SLGL | Sol-Gel Technologies Ltd. | 228.76M | -1.24% | 16,047 | 19.39M |
| 309 | CAMP | Camp4 Therapeutics Corporation | 228.47M | -1.35% | 81,333 | 3.93M |
| 310 | ALEC | Alector, Inc. | 227.60M | -2.38% | 389,060 | 18.42M |
| 311 | NKTX | Nkarta, Inc. | 226.71M | -0.31% | 498,151 | - |
| 312 | HUMA | Humacyte, Inc. | 222.02M | -5.66% | 8,062,858 | 2.04M |
| 313 | CNTX | Context Therapeutics Inc. | 219.59M | 0.42% | 468,945 | - |
| 314 | TNYA | Tenaya Therapeutics, Inc. | 216.59M | -0.19% | 15,258,441 | 225.00K |
| 315 | ELTX | Elicio Therapeutics, Inc. | 213.58M | 17.15% | 335,212 | - |
| 316 | UNCY | Unicycive Therapeutics, Inc. | 212.27M | 0.13% | 384,751 | - |
| 317 | MDWD | MediWound Ltd. | 211.55M | -0.66% | 74,038 | 16.96M |
| 318 | RNA | Atrium Therapeutics, Inc. | 205.57M | 1.38% | 169,889 | 18.62M |
| 319 | DTIL | Precision BioSciences, Inc. | 202.81M | 2.21% | 187,387 | 45.07M |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 200.44M | 0.14% | 273,687 | 17.56M |
| 321 | CRBU | Caribou Biosciences, Inc. | 199.47M | 4.64% | 1,891,300 | 11.20M |
| 322 | KPTI | Karyopharm Therapeutics Inc. | 198.61M | 1.97% | 466,729 | 146.07M |
| 323 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 195.81M | 0.73% | 261,970 | - |
| 324 | TLSA | Tiziana Life Sciences Ltd | 195.26M | -2.22% | 113,996 | - |
| 325 | WHWK | Whitehawk Therapeutics, Inc. | 187.83M | -4.28% | 204,283 | 7.15M |
| 326 | MGNX | MacroGenics, Inc. | 187.50M | -1.67% | 890,948 | 149.50M |
| 327 | ORMP | Oramed Pharmaceuticals Inc. | 186.86M | 12.96% | 607,111 | 2.00M |
| 328 | ABOS | Acumen Pharmaceuticals, Inc. | 185.62M | 0.39% | 430,573 | - |
| 329 | HRTX | Heron Therapeutics, Inc. | 180.82M | -21.05% | 8,533,102 | 150.71M |
| 330 | CNTN | Canton Strategic Holdings, Inc. | 180.73M | 5.63% | 780,474 | - |
| 331 | IFRX | InflaRx N.V. | 180.73M | -3.10% | 3,990,572 | 33.82K |
| 332 | ENLV | Enlivex Ltd. | 179.15M | -3.48% | 275,344 | - |
| 333 | PYXS | Pyxis Oncology, Inc. | 172.85M | 0.36% | 756,528 | 13.86M |
| 334 | ANTX | AN2 Therapeutics, Inc. | 169.90M | 5.83% | 213,676 | - |
| 335 | PRQR | ProQR Therapeutics N.V. | 169.63M | 1.90% | 576,084 | 19.19M |
| 336 | BDTX | Black Diamond Therapeutics, Inc. | 168.47M | -1.67% | 1,237,753 | 70.00M |
| 337 | KRRO | Korro Bio, Inc. | 165.28M | -4.90% | 129,489 | 3.84M |
| 338 | IMUX | Immunic, Inc. | 163.20M | 3.18% | 239,036 | - |
| 339 | KZIA | Kazia Therapeutics Limited | 161.12M | -2.35% | 199,611 | 1.27M |
| 340 | PLYX | Polaryx Therapeutics, Inc. | 160.49M | -7.38% | 68,169 | - |
| 341 | MENS | Jyong Biotech Ltd. | 159.18M | 0.98% | 65,753 | - |
| 342 | PLX | Protalix BioTherapeutics, Inc. | 156.31M | - | 604,095 | 52.74M |
| 343 | MOLN | Molecular Partners AG | 153.08M | 0.73% | 16,996 | 856.30K |
| 344 | HURA | TuHURA Biosciences, Inc. | 152.59M | 0.84% | 459,211 | - |
| 345 | SPRB | Spruce Biosciences, Inc. | 152.41M | -0.18% | 45,687 | 697.00K |
| 346 | SPRO | Spero Therapeutics, Inc. | 147.65M | -0.39% | 431,855 | 66.80M |
| 347 | GALT | Galectin Therapeutics Inc. | 145.48M | 5.24% | 654,298 | - |
| 348 | EQ | Equillium, Inc. | 142.26M | 6.64% | 122,211 | 4.39M |
| 349 | IPHA | Innate Pharma S.A. | 139.54M | 4.96% | 4,915 | 10.57M |
| 350 | OKUR | OnKure Therapeutics, Inc. | 138.96M | -12.02% | 301,868 | - |
| 351 | NTHI | NeOnc Technologies Holdings, Inc. | 138.54M | 0.92% | 121,655 | 39.99K |
| 352 | ALPS | Alps Group Inc | 138.11M | 1.08% | 33,093 | 3.74M |
| 353 | EDSA | Edesa Biotech, Inc. | 135.77M | -6.26% | 273,121 | - |
| 354 | CNTB | Connect Biopharma Holdings Limited | 132.26M | -0.85% | 115,061 | 64.00K |
| 355 | ACOG | Alpha Cognition Inc. | 129.56M | -2.46% | 8,688 | 10.22M |
| 356 | GNLX | Genelux Corporation | 128.79M | -6.75% | 210,064 | 8.00K |
| 357 | VRCA | Verrica Pharmaceuticals Inc. | 127.12M | -7.38% | 42,887 | 35.58M |
| 358 | AGEN | Agenus Inc. | 125.18M | -14.66% | 2,016,183 | 114.20M |
| 359 | AARD | Aardvark Therapeutics, Inc. | 124.79M | 5.15% | 152,603 | - |
| 360 | GUTS | Fractyl Health, Inc. | 122.00M | 1.89% | 3,183,139 | 3.00K |
| 361 | PEPG | PepGen Inc. | 117.59M | -3.41% | 608,462 | - |
| 362 | INO | Inovio Pharmaceuticals, Inc. | 117.17M | -2.05% | 8,046,154 | 65.34K |
| 363 | TTRX | Turn Therapeutics Inc. | 115.58M | 2.37% | 9,674 | - |
| 364 | BMEA | Biomea Fusion, Inc. | 113.51M | 1.95% | 1,559,678 | - |
| 365 | CRDF | Cardiff Oncology, Inc. | 111.44M | -0.61% | 579,217 | 593.00K |
| 366 | KLRS | Kalaris Therapeutics, Inc. | 108.75M | -6.89% | 155,327 | - |
| 367 | RANI | Rani Therapeutics Holdings, Inc. | 106.80M | 10.82% | 2,331,519 | 1.63M |
| 368 | ALDX | Aldeyra Therapeutics, Inc. | 106.17M | 1.73% | 713,242 | - |
| 369 | CGTX | Cognition Therapeutics, Inc. | 105.44M | -2.48% | 957,239 | - |
| 370 | CBUS | Cibus, Inc. | 105.27M | -4.17% | 237,747 | 3.64M |
| 371 | ONCY | Oncolytics Biotech Inc. | 104.93M | 1.54% | 826,140 | - |
| 372 | VANI | Vivani Medical, Inc. | 103.48M | 0.84% | 139,048 | - |
| 373 | SEER | Seer, Inc. | 103.25M | -2.41% | 133,317 | 16.58M |
| 374 | CUE | Cue Biopharma, Inc. | 101.96M | -10.51% | 225,590 | 27.47M |
| 375 | ANIX | Anixa Biosciences, Inc. | 101.59M | 1.00% | 125,870 | - |
| 376 | ENGN | enGene Therapeutics Inc. | 99.81M | -0.67% | 5,659,507 | - |
| 377 | COYA | Coya Therapeutics, Inc. | 98.05M | 1.70% | 144,119 | 7.95M |
| 378 | PMN | ProMIS Neurosciences, Inc. | 95.77M | 8.65% | 61,714 | - |
| 379 | LONA | LeonaBio, Inc. | 94.03M | -0.30% | 23,591 | - |
| 380 | NRXS | NeurAxis, Inc. | 93.77M | -0.61% | 268,190 | 3.57M |
| 381 | ATYR | aTyr Pharma, Inc. | 93.17M | 0.41% | 1,116,575 | 190.00K |
| 382 | NRXP | NRx Pharmaceuticals, Inc. | 93.16M | -8.44% | 1,349,036 | 1.23M |
| 383 | PTHS | Pelthos Therapeutics Inc. | 90.10M | 5.29% | 81,263 | 16.80M |
| 384 | RNTX | Rein Therapeutics Inc. | 89.74M | -5.74% | 617,200 | - |
| 385 | QTTB | Q32 Bio Inc. | 87.83M | -3.54% | 176,468 | 53.74M |
| 386 | OKYO | OKYO Pharma Limited | 86.59M | 1.23% | 9,940 | - |
| 387 | ACET | Adicet Bio, Inc. | 85.79M | -4.44% | 198,723 | - |
| 388 | PYPD | PolyPid Ltd. | 83.97M | 0.46% | 49,618 | - |
| 389 | CSBR | Champions Oncology, Inc. | 83.46M | -0.17% | 17,924 | 57.95M |
| 390 | EXOZ | eXoZymes, Inc. | 83.09M | 1.87% | 1,481 | -700.00 |
| 391 | ANVS | Annovis Bio, Inc. | 82.53M | 4.82% | 861,254 | - |
| 392 | ACRV | Acrivon Therapeutics, Inc. | 81.75M | -3.54% | 549,441 | - |
| 393 | GOSS | Gossamer Bio, Inc. | 79.49M | 3.58% | 3,055,557 | 48.47M |
| 394 | MAIA | MAIA Biotechnology, Inc. | 79.48M | -0.76% | 626,380 | - |
| 395 | ATHE | Alterity Therapeutics Limited | 78.94M | 3.00% | 36,012 | 4.43M |
| 396 | GANX | Gain Therapeutics, Inc. | 77.63M | - | 537,278 | - |
| 397 | ICCC | ImmuCell Corporation | 76.45M | 4.97% | 15,190 | 27.64M |
| 398 | PLRX | Pliant Therapeutics, Inc. | 75.54M | -1.64% | 185,600 | - |
| 399 | MCRB | Seres Therapeutics, Inc. | 75.52M | 1.82% | 34,282 | 1.15M |
| 400 | XBIT | XBiotech Inc. | 75.30M | 0.81% | 40,150 | - |
| 401 | ATRA | Atara Biotherapeutics, Inc. | 74.74M | 5.28% | 943,023 | 120.77M |
| 402 | FBIO | Fortress Biotech, Inc. | 74.41M | -6.28% | 453,996 | 63.26M |
| 403 | PMVP | PMV Pharmaceuticals, Inc. | 74.13M | -1.42% | 259,591 | - |
| 404 | RLYB | Rallybio Corporation | 74.06M | -2.64% | 176,686 | 858.00K |
| 405 | KALA | KALA BIO, Inc. | 72.69M | -1.39% | 188,737 | - |
| 406 | PDSB | PDS Biotechnology Corporation | 72.56M | 4.00% | 1,047,571 | - |
| 407 | OSTX | OS Therapies Incorporated | 71.89M | 3.01% | 479,988 | - |
| 408 | TCRX | TScan Therapeutics, Inc. | 70.92M | -6.35% | 1,100,177 | 9.14M |
| 409 | ACTU | Actuate Therapeutics, Inc. | 70.54M | -9.85% | 687,571 | - |
| 410 | MNOV | MediciNova, Inc. | 69.40M | 0.71% | 14,673 | 409.66K |
| 411 | IBO | Impact BioMedical Inc. | 67.39M | -0.64% | 37,868 | 32.00K |
| 412 | HYFT | MindWalk Holdings Corp. | 65.56M | 3.94% | 366,114 | 20.70M |
| 413 | IMA | ImageneBio, Inc. | 62.75M | 6.05% | 67,706 | 800.00K |
| 414 | BYSI | BeyondSpring Inc. | 62.50M | 2.01% | 17,532 | 1.88M |
| 415 | IMMP | Immutep Limited | 62.04M | -0.65% | 705,725 | 5.28M |
| 416 | FLNA | Filana Therapeutics, Inc. | 61.83M | -1.54% | 236,503 | - |
| 417 | CING | Cingulate Inc. | 60.76M | -5.88% | 574,622 | - |
| 418 | IBIO | iBio, Inc. | 60.00M | -2.92% | 663,696 | 300.00K |
| 419 | LIXT | Lixte Biotechnology Holdings, Inc. | 59.83M | -0.19% | 96,109 | - |
| 420 | DWTX | Dogwood Therapeutics, Inc. | 56.45M | 2.42% | 90,872 | - |
| 421 | TIL | Instil Bio, Inc. | 55.14M | -0.37% | 25,594 | - |
| 422 | ENTX | Entera Bio Ltd. | 54.55M | -10.00% | 128,365 | 42.00K |
| 423 | INKT | MiNK Therapeutics, Inc. | 54.38M | -0.82% | 45,359 | - |
| 424 | KZR | Kezar Life Sciences, Inc. | 53.86M | -0.95% | - | - |
| 425 | ESLA | Estrella Immunopharma, Inc. | 53.76M | - | 18,449 | - |
| 426 | HYPD | Hyperion DeFi, Inc. | 51.57M | 0.83% | 202,801 | 813.46K |
| 427 | MGX | Metagenomi Therapeutics, Inc. | 50.82M | -4.26% | 226,340 | 25.21M |
| 428 | RADX | Radiopharm Theranostics Limited | 48.88M | - | 139,255 | 10.86M |
| 429 | ATOS | Atossa Therapeutics, Inc. | 47.36M | -1.79% | 37,711 | - |
| 430 | XLO | Xilio Therapeutics, Inc. | 46.25M | -0.13% | 19,819 | 43.77M |
| 431 | LITS | Lite Strategy, Inc. | 45.09M | 1.64% | 610,813 | - |
| 432 | NTRB | Nutriband Inc. | 44.37M | -2.67% | 9,639 | 2.04M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 44.35M | -0.77% | 89,404 | - |
| 434 | ATNM | Actinium Pharmaceuticals, Inc. | 41.78M | 2.29% | 129,761 | 90.00K |
| 435 | PSTV | Plus Therapeutics, Inc. | 41.45M | -1.31% | 135,864 | 5.21M |
| 436 | MREO | Mereo BioPharma Group plc | 38.71M | -2.84% | 2,984,512 | 500.00K |
| 437 | ALGS | Aligos Therapeutics, Inc. | 38.43M | -3.57% | 136,128 | 4.71M |
| 438 | RNXT | RenovoRx, Inc. | 38.29M | -1.57% | 224,358 | 1.12M |
| 439 | TVRD | Tvardi Therapeutics, Inc. | 37.15M | -5.26% | 60,058 | - |
| 440 | DARE | Daré Bioscience, Inc. | 36.69M | -8.36% | 755,610 | 1.03M |
| 441 | PTN | Palatin Technologies, Inc. | 36.56M | -2.41% | 11,259 | 8.96M |
| 442 | GRCE | Grace Therapeutics, Inc. | 36.36M | 0.43% | 291,262 | - |
| 443 | INMB | INmune Bio Inc. | 35.89M | -5.59% | 159,022 | 50.00K |
| 444 | VERU | Veru Inc. | 35.47M | -1.34% | 57,784 | 16.89M |
| 445 | PLUR | Pluri Inc. | 35.38M | 1.00% | 8,812 | 1.34M |
| 446 | NXTC | NextCure, Inc. | 35.30M | 0.26% | 17,336 | - |
| 447 | EVAX | Evaxion A/S | 35.24M | -2.65% | 41,278 | 7.53M |
| 448 | CRVO | CervoMed Inc. | 35.18M | -3.80% | 56,522 | 4.01M |
| 449 | BOLD | Boundless Bio, Inc. | 34.75M | 7.64% | 332,829 | - |
| 450 | NNVC | NanoViricides, Inc. | 32.18M | -3.87% | 611,057 | - |
| 451 | APLM | Apollomics, Inc. | 32.17M | -5.18% | 2,774 | 8.84M |
| 452 | HOWL | Werewolf Therapeutics, Inc. | 32.10M | -2.87% | 638,803 | 1.14M |
| 453 | SNTI | Senti Biosciences Holdings, Inc. | 31.77M | 3.47% | 263,124 | 22.00K |
| 454 | SNSE | Sensei Biotherapeutics, Inc. | 31.36M | -11.41% | 25,122 | - |
| 455 | SKYE | Skye Bioscience, Inc. | 30.91M | 2.01% | 142,425 | - |
| 456 | PLRZ | Polyrizon Ltd. | 30.17M | -1.35% | 35,071 | - |
| 457 | BCTX | BriaCell Therapeutics Corp. | 30.03M | -0.72% | 96,077 | - |
| 458 | IGC | IGC Pharma, Inc. | 29.94M | -2.57% | 1,005,718 | 1.11M |
| 459 | QNTM | Quantum BioPharma Ltd. | 29.86M | 3.69% | 173,006 | - |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 29.52M | -5.11% | 95,103 | - |
| 461 | LSTA | Lisata Therapeutics, Inc. | 29.45M | 3.49% | 60,043 | 170.00K |
| 462 | TVGN | Tevogen Bio Holdings Inc. | 29.15M | -6.42% | 4,602 | - |
| 463 | BRNS | Barinthus Biotherapeutics plc | 27.98M | 2.24% | 49,538 | 14.97M |
| 464 | NEUP | Neuphoria Therapeutics Inc. | 27.87M | -2.64% | 12,256 | 14.99M |
| 465 | TPST | Tempest Therapeutics, Inc. | 27.83M | -2.51% | 72,747 | - |
| 466 | KYNB | Kyntra Bio, Inc. | 27.53M | -2.16% | 15,619 | 6.44M |
| 467 | VTGN | Vistagen Therapeutics, Inc. | 26.69M | 10.34% | 1,323,680 | 789.00K |
| 468 | DYAI | Dyadic International, Inc. | 26.39M | -5.52% | 108,549 | 3.09M |
| 469 | JSPR | Jasper Therapeutics, Inc. | 26.38M | 1.72% | 213,457 | - |
| 470 | ALLR | Allarity Therapeutics, Inc. | 25.97M | 8.39% | 411,913 | 320.00K |
| 471 | OTLK | Outlook Therapeutics, Inc. | 25.91M | 11.93% | 5,089,352 | 205.70K |
| 472 | ABVC | ABVC BioPharma, Inc. | 25.20M | -3.77% | 78,159 | 797.92K |
| 473 | LGVN | Longeveron Inc. | 24.53M | -0.86% | 486,467 | 1.20M |
| 474 | MRKR | Marker Therapeutics, Inc. | 24.34M | -0.68% | 64,142 | 3.55M |
| 475 | SER | Serina Therapeutics, Inc. | 23.84M | -8.57% | 128,347 | 130.00K |
| 476 | LTRN | Lantern Pharma Inc. | 23.43M | -0.48% | 131,468 | - |
| 477 | AEON | AEON Biopharma, Inc. | 23.20M | -2.00% | 85,485 | - |
| 478 | CELU | Celularity Inc. | 22.21M | -12.49% | 305,941 | 26.55M |
| 479 | VYNE | VYNE Therapeutics Inc. | 22.14M | 0.59% | 124,052 | 570.00K |
| 480 | CRIS | Curis, Inc. | 22.03M | -1.78% | 206,924 | 9.44M |
| 481 | XCUR | Exicure, Inc. | 21.54M | 0.30% | 9,674 | 500.00K |
| 482 | TRAW | Traws Pharma, Inc. | 20.52M | -7.34% | 25,876,025 | 2.79M |
| 483 | QNCX | Quince Therapeutics, Inc. | 20.21M | -3.13% | 549,084 | - |
| 484 | GRDX | GridAI Technologies Corp. | 19.78M | -6.73% | 87,925 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 19.73M | -0.52% | 131,694 | - |
| 486 | OSRH | OSR Holdings, Inc. | 18.81M | -0.47% | 1,395,823 | 2.91M |
| 487 | LPCN | Lipocine Inc. | 18.62M | -2.11% | 138,443 | 2.00M |
| 488 | ICU | SeaStar Medical Holding Corporation | 18.31M | 2.00% | 37,744 | 1.23M |
| 489 | COCP | Cocrystal Pharma, Inc. | 17.92M | -9.72% | 186,802 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 17.31M | -0.22% | 692,749 | 3.94M |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 17.00M | -9.32% | 91,007 | - |
| 492 | INAB | IN8bio, Inc. | 16.00M | 2.85% | 67,663 | - |
| 493 | TOVX | Theriva Biologics, Inc. | 15.65M | -3.67% | 2,865,471 | 300.00K |
| 494 | NCEL | NewcelX Ltd. | 15.27M | -0.30% | 30,876 | - |
| 495 | LEXX | Lexaria Bioscience Corp. | 14.99M | -0.82% | 95,250 | 368.00K |
| 496 | GNTA | Genenta Science S.p.A. | 14.86M | 0.57% | 57,638 | - |
| 497 | PASG | Passage Bio, Inc. | 14.11M | 4.51% | 61,655 | - |
| 498 | HIND | Vyome Holdings, Inc. | 13.83M | -4.37% | 45,639 | 319.71K |
| 499 | BLRX | BioLineRx Ltd. | 13.50M | -2.93% | 9,081 | 1.18M |
| 500 | CYCN | Cyclerion Therapeutics, Inc. | 13.48M | 2.90% | 48,237 | 2.07M |